The contested director elections and 31% against vote on the equity plan signal shareholder unease. Monitor for any follow-up activist filings or board-level changes. The evergreen provision could lead to material dilution over time, but no immediate catalyst.
Price Chart
Executive Summary
Zura Bio shareholders approved an amended equity incentive plan at the June 17, 2026 Annual Meeting, increasing the share pool to 9,594,213 shares with annual evergreen increases through 2029. All eight director nominees were elected, though two directors (Jennifer Jarrett and Amit Munshi) received ~29% 'against' votes, and the plan itself saw 31% opposition, reflecting shareholder dissent in the context of a recent proxy contest.
Key Facts
- Shareholders approved the Amended 2023 Equity Incentive Plan with 38,850,373 For, 17,403,607 Against, 26,663 Abstain, and 18,267,509 broker non-votes.
- Maximum aggregate shares issuable under the plan is 9,594,213, with annual evergreen increases starting January 1, 2024 through 2029.
- All eight director nominees were elected; Jennifer Jarrett (39.8M For, 16.5M Against) and Amit Munshi (40.2M For, 16.0M Against) faced significant opposition.
- Ratification of WithumSmith+Brown as auditor passed with 74,323,697 For, 30,527 Against.
- Director Someit Sidhu resigned on May 21, 2026, not due to any disagreement with the company (per cross-filing DEFA14A).
Financial Impact
Potential dilution from up to 9.59M new shares plus annual evergreen increases; no immediate financial impact reported.
Risk Factors
- Ongoing shareholder dissent may lead to further proxy contests or governance changes.
- Equity plan dilution could pressure stock if shares are issued aggressively.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-075826 |
| Document: tm2618327d1_8k.htm | 0001104659-26-075826 |
| Document: 0001104659-26-075826-index-headers.html | 0001104659-26-075826 |
| Document: 0001104659-26-075826-index.html | 0001104659-26-075826 |
| Document: 0001104659-26-075826.txt | 0001104659-26-075826 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $3.35 | awaiting T+20 | — | $4.14 (+23.58%) |
Aug 17, 2026 10w ago | 8-K | $5.68 $4.93 | ▼ −13.20% | ▼ −11.23% | $4.14 (−27.11%) |
Aug 11, 2026 11w ago | 8-K | $5.56 $5.71 | ▲ +2.70% | ▲ +3.76% | $4.14 (−25.54%) |
Jul 1, 2026 16w ago | 8-K | $5.01 $5.31 | ▲ +6.09% | ▲ +8.28% | $4.14 (−17.28%) |
Jun 18, 2026 18w ago | 8-K | $4.23 $5.45 | ▲ +28.84% | ▲ +28.99% | $4.14 (−2.13%) |
May 7, 2026 24w ago | 8-K | $4.54 $3.86 | ▼ −14.98% | ▼ −18.11% | $4.14 (−8.81%) |
Mar 5, 2026 33w ago | 8-K | $6.76 $6.03 | ▼ −10.80% | ▼ −7.01% | $4.14 (−38.76%) |
Feb 26, 2026 34w ago | 8-K | $6.77 $6.04 | ▼ −10.78% | ▼ −4.38% | $4.14 (−38.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers